image description

Louanne Mattioli

Amento Tech
img description

Unique Id :DIPP10659/2017/KSUM165
DIPP NO : :DIPP10659

Since October,05 2017
Linked In
Thiruvathira, Vellanchira, Panavoor P.O, Nedumangad, Thiruvananthapuram

B-Aegis Life Sciences & Research Private Limited

  • Sector : Life Sciences,HealthTech
  • Sub Sector: Biopharma (by Disease),Biopharma (by Therapy),Diagnostics (by Disease),Biotech R&D
  • Technology: Nanotechnology

Product Usecase

Cancer Diagnosis, Cancer Screening, Cancer Treatment, MRI Scanning, Contrast-enhanced MR angiography (CE-MRA), Targeted Drug Delivery, siRNA Delivery, Nuclease Delivery, NK Cell optimization, TAM Activation

Product Details

OncoSense® is a next-generation Superparamagnetic Iron Oxide (Fe3O4) Nanoparticles based MRI Contrast agent and drug delivery vehicle, conjugated with a patent pending tumour targeting peptide. OncoSense® is highly sensitive towards the early stage (sometimes even in the transitional stage)  adenocarcinomas and squamous cell carcinomas. It can also target almost all types of epithelial origin solid tumours at later stages (from Stage II), including pancreatic tumour as OncoSenseⓇ can break thick tumour stroma along with stromal secretions because of its distinct surface modification technique. OncoSenseⓇ is most sensitive to the changes in molecular information rather than anatomic changes, which helps in the early detection of hidden micrometastasis.

Keralastartupmission © 2019 All Rights Reserved.